Ibrunat Ibrutinib – 140 mg Capsules (1 pack / 30 caps)

Buy Ibrunat 140 mg (30 Capsules) Ibrutinib Online

Ibrunat Ibrutinib – 140 mg Capsules (1 pack / 30 caps)

At a Glance

Generic Name: Ibrutinib

Brand Name: Ibrunat

Strength & Pack Size: Ibrunat 140 mg capsules – 1 pack / 30 caps

Dosage Form: Oral hard capsules for systemic use

Therapeutic Class: Bruton’s tyrosine kinase (BTK) inhibitor, targeted anticancer therapy

Main Indications: CLL, SLL, mantle cell lymphoma and Waldenström’s macroglobulinemia as indicated

Use in Therapy: Long-term oral targeted treatment for B-cell malignancies under haematology / oncology supervision

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Ibrunat 140 mg contains ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor used as targeted oral therapy in several B-cell blood cancers.
These include chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL) and Waldenström’s macroglobulinemia in adults,
according to approved indications and guideline-based protocols. As a generic ibrutinib 140 mg capsule, Ibrunat offers the same active ingredient and strength as the originator brand
while providing a more accessible option in USD for patients who require continuous BTK inhibitor therapy under specialist supervision.

Each Ibrunat 140 mg capsule contains 140 mg of ibrutinib. The 1 pack / 30 caps presentation fits typical ibrutinib treatment schedules,
in which several 140 mg capsules are taken once daily to reach the total daily dose prescribed by your haematologist or oncologist.
Depending on indication and protocol, this can be three capsules once daily (420 mg/day) or four capsules once daily (560 mg/day), but exact dosing is always determined by your treating team.
Ibrunat 140 mg ibrutinib capsules are usually given as a long-term, continuous treatment for CLL, SLL, MCL or Waldenström’s macroglobulinemia as long as clinical benefit is maintained and side effects remain manageable.

Ibrutinib works differently from traditional chemotherapy tablets. It selectively targets BTK, a key signalling molecule inside malignant B lymphocytes,
helping to interrupt the signals that drive cell survival and proliferation. For many patients, Ibrunat 140 mg becomes part of a long-term management strategy, sometimes after earlier lines of therapy,
sometimes as an earlier-line targeted option when recommended by guidelines. The once-daily oral dosing makes this BTK inhibitor a practical choice for ongoing at-home therapy with regular outpatient monitoring.

When you buy Ibrunat 140 mg online from Generic Meds Mart, you receive generic ibrutinib capsules supplied by licensed manufacturers and authorised distributors that comply with recognised GMP standards.
Original blisters and cartons show the product name, 140 mg strength, batch number and expiry date, while discreet outer packaging protects your privacy during shipping.

Key Uses

Ibrunat 140 mg ibrutinib capsules are generally used under specialist supervision for:

• Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in treatment-naïve or previously treated adults when a BTK inhibitor is indicated
• Mantle cell lymphoma (MCL) in adults who have received at least one prior therapy, according to guidelines
• Waldenström’s macroglobulinemia, alone or in combination regimens, under the care of an experienced haematology team

Your specialist will determine whether Ibrunat 140 mg is appropriate for your disease stage, prior therapies and overall clinical status.

How Ibrutinib Works in Chemotherapy

Ibrutinib is a highly selective inhibitor of Bruton’s tyrosine kinase (BTK), a key component of the B-cell receptor (BCR) signalling pathway.
In many B-cell malignancies, including CLL, SLL, mantle cell lymphoma and Waldenström’s macroglobulinemia, the BCR signalling cascade is abnormally active and supports tumour cell survival and proliferation.

By binding irreversibly to BTK, Ibrunat 140 mg ibrutinib capsules block downstream signalling from the B-cell receptor.
This disruption affects pathways that control cell survival, adhesion, trafficking and interactions with the bone marrow and lymph node microenvironment.
As a result, malignant B cells receive fewer survival signals, become more susceptible to apoptosis and are gradually cleared from the circulation and lymphoid tissues.

Because BTK is also present in some normal B cells and other cells involved in immunity and haemostasis, ibrutinib therapy can influence immune function and bleeding risk.
Careful monitoring by an experienced haematologist or oncologist is therefore essential throughout treatment with Ibrunat 140 mg.

Dosage & Administration

The dose and schedule of Ibrunat 140 mg must always be set by your treatment team, using current guidelines and product information.
Typical adult regimens involve once-daily oral dosing with several capsules to reach the target daily dose, but details vary by indication and by patient.

• Take Ibrunat 140 mg capsules by mouth once daily at approximately the same time each day, with a glass of water.
• Swallow Ibrunat capsules whole; do not open, crush or chew them unless your pharmacist gives specific handling advice.
• Follow your clinic’s instructions about taking ibrutinib with or without food; many centres recommend a consistent routine each day.
• Do not change your daily dose, skip doses or stop Ibrunat without clear guidance from your haematology or oncology team.
• If you miss a dose, follow the written instructions from your treatment centre; never double the next dose unless your doctor specifically tells you to.

Regular blood tests and clinical reviews will help your doctors decide whether your dose of Ibrunat 140 mg should remain the same or be adjusted.

Precautions

Before starting Ibrunat 140 mg ibrutinib capsules, inform your healthcare team about your full medical history and all medicines, supplements and herbal products you use. Key precautions include:

• History of bleeding problems or concurrent use of anticoagulants and antiplatelet drugs
• History of atrial fibrillation, other heart rhythm disturbances, heart failure or uncontrolled hypertension
• Previous serious infections, chronic viral infections or immunodeficiency
• Kidney or liver impairment that may affect ibrutinib metabolism and clearance
• Planned surgery or invasive dental procedures, because Ibrunat can increase bleeding risk and may need temporary interruption
• Concomitant use of strong CYP3A inhibitors or inducers that can alter blood levels of ibrutinib
• Pregnancy or breastfeeding; ibrutinib capsules are not recommended and may harm an unborn baby

Men and women of child-bearing potential are usually advised to use effective contraception during and for a period after Ibrunat 140 mg therapy, as directed by their doctor.

Ibrutinib Side Effects

Common side effects

Common side effects of Ibrunat 140 mg ibrutinib capsules may include:

• Diarrhea or loose stools
• Mild nausea or abdominal discomfort
• Bruising more easily than usual, small skin bleeds or petechiae
• Upper respiratory tract infections, cough or sinus congestion
• Muscle or joint pain, back pain or general aches
• Tiredness, fatigue or reduced energy levels
• Mild swelling of the ankles or feet

These effects are often manageable with supportive care or dose adjustments, but you should inform your treatment team about any persistent or worsening symptoms.

Serious side effects

Less common but serious side effects of ibrutinib require urgent medical attention and may include:

• Signs of major bleeding: blood in stools or urine, vomiting blood, coughing up blood or heavy unexplained bleeding
• Palpitations, chest pain, shortness of breath or a racing, irregular heartbeat suggestive of atrial fibrillation or other arrhythmia
• Fever, chills, severe sore throat or other signs of serious infection
• Severe, persistent headache, confusion, visual changes or neurological symptoms
• Significant shortness of breath, new or worsening swelling, or sudden weight gain hinting at cardiac or pulmonary complications

If you experience any of these serious symptoms while taking Ibrunat 140 mg, seek emergency care immediately and contact your haematology / oncology team.

Storage

• Store Ibrunat 140 mg ibrutinib capsules at room temperature, preferably below 25 °C.
• Keep capsules in their original blisters and outer carton to protect them from moisture and light.
• Keep all oncology medicines out of the sight and reach of children and pets.
• Do not use Ibrunat after the expiry date printed on the packaging.

Ask your pharmacist or treatment centre how to safely dispose of unused or expired Ibrunat 140 mg capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart is committed to providing safe, transparent access to key oncology medicines such as
Ibrunat 140 mg ibrutinib capsules at clear prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Ibrunat 140 mg online from Generic Meds Mart, you benefit from:

• Original ibrutinib 140 mg blisters and cartons from licensed suppliers
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured product information to support discussions with your haematology / oncology team
• Responsive customer support for questions about ordering, payment and delivery

Order Now

Ibrunat 140 mg ibrutinib capsules are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Ibrunat online, ensure your haematologist or oncologist has confirmed ibrutinib as part of your treatment plan and specified the daily dose and expected duration of therapy.

Select Ibrunat 140 mg (1 pack / 30 caps), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.